NanoViricides
NNVC
#10149
Rank
NZ$34.55 M
Marketcap
NZ$1.60
Share price
-3.50%
Change (1 day)
-25.63%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): NZ-$1.03

According to NanoViricides's latest financial reports the company's current EPS (TTM) is NZ-$1.01. an increase over its 2024 EPS that were of NZ-$1.16.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025NZ-$1.05-10%
2024NZ-$1.16-5.41%
2023NZ-$1.235.71%
2022NZ-$1.16-13.58%
2021NZ-$1.34-66.11%
2020NZ-$3.971.7%
2019NZ-$3.90-10.98%
2018NZ-$4.38-22.35%
2017NZ-$5.65-10.53%
2016NZ-$6.31375%
2015NZ-$1.33-85.19%
2014NZ-$8.9742.11%
2013NZ-$6.3126.67%
2012NZ-$4.98-6.25%
2011NZ-$5.3114.28%
2010NZ-$4.65100%
2009NZ-$2.32-0%
2008NZ-$2.32-33.33%
2007NZ-$3.49-0%
2006NZ-$3.494445.07%
2005NZ-$0.07672

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
NZ$10.83-1,168.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.61-1,344.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$4.93-586.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.97-689.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
NZ$3.52-447.54%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ-$0.08302-91.80%๐Ÿ‡บ๐Ÿ‡ธ USA